CAMP anticorps

N° du produit ABIN487626

L’anticorps Mouton Polyclonal anti-CAMP a été validé pour EIA. Il convient pour détecter CAMP dans des échantillons de .

Aperçu rapide pour CAMP anticorps (ABIN487626)

Antigène: CAMP (cAMP) (Cyclic Adenosine Monophosphate (cAMP))

Reactivité: Veuillez nous consulter SVP

Hôte: Mouton

Clonalité: Polyclonal

Conjugué: Cet anticorp CAMP est non-conjugé

Application: Enzyme Immunoassay (EIA)

Détail du produit anti-CAMP anticorps

Purification: Ig Fraction

Immunogène: Cyclic AMP-BSA

Isotype: IgG

Information d'application

Indications d'application: ELISA: 6.05 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 6.05mg/mL (U.V. abs at 280nm)

Buffer: 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: -20 °C

Détails sur CAMP

Antigène: CAMP (cAMP) (Cyclic Adenosine Monophosphate (cAMP))

Autre désignation: cAMP / Cyclic AMP

Classe de substances: Chemical

Sujet: Cyclic adenosine monophosphate (cAMP) plays a key role as an intracellular second messenger for transduction events that follow a number of extracellular signals. The G-Protein Coupled Receptors (GPCR) is the largest family of cell surface receptors. They can be activated by different ligands, such as neurotransmitters, hormones, ions, small molecules, peptides, and other physiological signaling molecules. Typically, the binding of the ligands to its receptor resulting in the activation of G-proteins, in return, activates the effector adenylyl cyclase evoking the production of cAMP. The activation of a protein kinase by cAMP results in the phosphorylation of substrate proteins. Currently successful drugs in marketing have been developed to target these receptors. Among the GPCRs, ~367 receptors are potential drug development targets, but only about 20 have been used to generate therapeutically and commercially successful drugs so far. Because the involvement of cAMP can amplify the response of the ligand binding, the second messenger cAMP has been largely employed to monitor the activation of the GPCR to facilitate the therapeutic drug discovery.

Pathways: Cellular Response to Molecule of Bacterial Origin